Work

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial

Year: 2000

Type: article

Source: Obstetrical & Gynecological Survey

DOI: 10.1097/00006254-200002000-00023

Authors: Steven R. Cummings, Stephen Eckert, Kathryn A. Krueger, Deborah Grady, Trevor J. Powles, Jane A. Cauley, Larry Norton, Thomas Nickelsen, Nina H. Bjarnason, Monica Morrow, Marc E. Lippman, Dennis Black, Joan E. Glusman, Alberto Costa, V. Craig Jordan

Institutions: Northwestern University, Royal Marsden NHS Foundation Trust, Memorial Sloan Kettering Cancer Center, Eli Lilly (United States), University of Pittsburgh, University of California, San Francisco, Georgetown University Medical Center, Royal Marsden Hospital, Center for Clinical & Basic Research, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Georgetown Lombardi Comprehensive Cancer Center, European Institute of Oncology

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2320446229

FWCI: 4.495

Cites:

Cited by: 92

Related to: 10